神經(jīng)鈣黏蛋白(NCAD)重組蛋白
Recombinant N-cadherin (NCAD)
CDw325; CD325; CDHN; CDH2; Cadherin 2 Type 1; N-Cadherin
- 編號RPB481Hu02
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 來源原核表達
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
 - 亞細胞定位細胞膜
 - 預(yù)測分子量11.7kDa
 - 實際分子量26kDa(差異分析請參閱說明書)
 - 片段與標簽Ser685~Asp784 with N-terminal His Tag
 - 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
 - 性狀凍干粉
 - 純度> 97%
 - 等電點5.2
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價格¥ 984¥ 2460¥ 4920¥ 14760¥ 36900
 - 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
序列

用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPB481Hu02 | 神經(jīng)鈣黏蛋白(NCAD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB481Hu01 | 神經(jīng)鈣黏蛋白(NCAD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB481Hu01 | 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體 | WB | 
| PAB481Hu02 | 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體 | WB; IHC | 
| LAB481Hu71 | 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體(生物素標記) | WB | 
| MAB481Hu22 | 神經(jīng)鈣黏蛋白(NCAD)單克隆抗體 | WB; IHC; ICC; IP. | 
| SEB481Hu | 神經(jīng)鈣黏蛋白(NCAD)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB481Hu | 神經(jīng)鈣黏蛋白(NCAD)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻
| 雜志 | 參考文獻 | 
| Toxicology Letters | Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.[Pubmed: 23830989] | 
| British journal of haematology | Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.[Pubmed: 23438504] | 
| JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease[Pubmed: 32296844] | 
| Cell Biol Toxicol | ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer[33566221] | 
| CELL BIOLOGY AND TOXICOLOGY | Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence[33758996] | 
| Pharmacol Res | DOC2B is a Negative Regulator of Wnt/β-catenin Signaling Pathway in Cervical Cancer[Pubmed:35500882] | 



